Follow-The-Filings

Security · featured owners

MCK Mckesson Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 9.2%
  • $349M
  • 2 add 1 reduce 1 exit

MCK (Mckesson Corp.) is held in 3 featured 13F books as of 2026 Q2. Mala Gaonkar - Surgocap Partners is the largest tracked holder by portfolio weight (9.2%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 9.2% (Mala Gaonkar - Surgocap Partners) · not free-float ownership

  1. Mala Gaonkar add 9.2%
  2. Muhlenkamp & Co. add 6.0%
  3. Stephen Mandel reduce 0.27%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Mala Gaonkar - Surgocap Partners 2026 Q2 9.2% Add +8.1% 376,870 $285M history
Stephen Mandel - Lone Pine Capital 2026 Q2 0.27% Reduce −85.3% 57,851 $44M history
Muhlenkamp & Co. 2026 Q2 6.0% Add +0.1% 27,202 $21M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 1.2% Exit −1.16% 234,300 $203M history

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026 Filing Doc
4 Period Aug 10, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Jul 22, 2026 · 10 forms Filing Doc
4 Period Jul 7, 2026 Filing Doc
4 Period Jun 17, 2026 Filing Doc
4 Period Jun 9, 2026 Filing Doc
4 Period Jun 5, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 29, 2026 Filing Doc
4 Period May 23, 2026 · 5 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $276.71B $308.95B $359.05B $403.43B
Gross profit $12.36B $12.83B $13.32B $14.55B
Gross margin * 4.5% 4.2% 3.7% 3.6%
Net income $3.56B $3B $3.3B $4.76B
Net margin * 1.3% 1.0% 0.9% 1.2%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $44.29B $47.97B $55.4B $57.21B
Total non-current assets * $18.03B $19.47B $19.74B $25.11B
Total assets $62.32B $67.44B $75.14B $82.32B
Total current liabilities $47.96B $52.36B $61.6B $67.02B
Total equity -$1.86B -$1.97B -$2.07B -$2.17B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $5.16B $4.31B $6.08B $6.16B
Cash from investing -$0.542B -$1.07B -$0.733B -$3.43B
Cash from financing -$4.37B -$3.34B -$3.96B -$4.63B
Net change in cash $0.744B -$0.094B $1.37B -$1.89B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders